Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.69 (
APC
)
16,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We examined whether
activated protein C
(
APC
) reduces ischemia/reperfusion (I/R)-induced renal injury by inhibiting leukocyte activation. In a rat model, intravenous administration of
APC
markedly reduced I/R-induced renal dysfunction and histological changes, whereas intravenous administration of dansyl glutamylglycylarginyl chloromethyl ketone-treated factor Xa (DEGR-FXa; active-site-blocked factor Xa), heparin or diisopropyl fluorophosphate-treated
APC
(DIP-
APC
; inactive derivative of
ARC
) had no effect. Furthermore,
APC
significantly inhibited the I/R-induced decrease in renal tissue blood flow and the increase in the vascular permeability, whereas neither DEGR-FXa, heparin, nor DIP-
APC
produced such effects. Renal I/R-induced increases in plasma levels of fibrin degradation products were significantly inhibited by
APC
, DEGR-FXa, and heparin. These observations suggest that
APC
reduces I/R-induced renal injury independently of its anticoagulant effects but in a manner dependent on its serine protease activity. Renal levels of tumor necrosis factor-alpha (TNF-alpha), rat interleukin-8, and myeloperoxidase were significantly increased after renal I/R. These increases were significantly inhibited by
APC
but not by DEGR-FXa, heparin, or DIP-
APC
. Leukocytopenia produced effects similar to those of
APC
. These findings strongly suggest that
APC
protects against I/R-induced renal injury not by inhibiting coagulation abnormalities but by inhibiting activation of leukocytes that play an important role in I/R-induced renal injury. Inhibition of leukocyte activation by
APC
could be explained by the inhibitory activity of TNF-alpha. (Blood. 2000;95:3781-3787)
...
PMID:Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. 2354 58
This study investigated the effect of coinitiator solutions and self-adhesive resin cement on the early retention of glass-fiber posts. Cylindrical glass-fiber posts were luted into 40 incisor roots with different adhesion strategies (n = 10): SB2, Single Bond 2 + conventional resin cement (RelyX
ARC
); AP, Scotchbond Multipurpose Plus (SBMP) activator + primer +
ARC
;
APC
, SBMP activator + primer + catalyst +
ARC
; and UNI, self-adhesive cement (RelyX Unicem). Pull-out bond strength results at 10 min after cementation showed
APC
> UNI > SB2 = AP (P < 0.05). The adhesion strategy significantly affected early bonding to root canals.
...
PMID:Adhesion strategy and early bond strengths of glass-fiber posts luted into root canals. 2289 80